I agree...
Remember, we got a Fast Track based on what?
Read the above, we got a FT based on that submission3. That's littered with evidence of the 2 x 2 or even greater...Our Phase 2B 005, even EAP (USA!) and GHOSH and KUMAGAI studies
GHOSH's study was 3mg/kg !
Kumagai?
EAP Program (In USA)
All of these program's data was submitted as the basis for FT acceptance, the dosings were all 2mg/kg or greater.
REFRENCES
1) https://pubmed.ncbi.nlm.nih.gov/24678076/
2) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2873929/
3) https://app.sharelinktechnologies.com/announcement/asx/d3ce3910e046ad93af80e361326f9d48
4) https://app.sharelinktechnologies.com/announcement/asx/53eb6ac3e5970e6fdf32dccc78411a3d
Ann: PAR to present at NWR Healthcare Conference, page-31
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.5¢ |
Change
0.010(4.08%) |
Mkt cap ! $89.19M | |||
| Open | High | Low | Value | Volume |
| 24.5¢ | 26.0¢ | 24.5¢ | $65.17K | 254.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 64000 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 26.0¢ | 14407 | 2 |
View Market Depth
| Last trade - 16.10pm 01/08/2024 (20 minute delay) ? |
| PAR (ASX) Chart |